Free Trial

Innoviva (INVA) Stock Price, News & Analysis

Innoviva logo
$18.97 -0.09 (-0.46%)
As of 11:02 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Innoviva Stock (NASDAQ:INVA)

Key Stats

Today's Range
$18.81
$19.40
50-Day Range
$18.01
$21.80
52-Week Range
$16.67
$22.00
Volume
141,945 shs
Average Volume
700,903 shs
Market Capitalization
$1.19 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$40.50
Consensus Rating
Buy

Company Overview

Innoviva Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
88th Percentile Overall Score

INVA MarketRank™: 

Innoviva scored higher than 88% of companies evaluated by MarketBeat, and ranked 146th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Innoviva has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Innoviva has only been the subject of 1 research reports in the past 90 days.

  • Read more about Innoviva's stock forecast and price target.
  • Earnings Growth

    Earnings for Innoviva are expected to grow by 369.70% in the coming year, from $0.33 to $1.55 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Innoviva is -18.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Innoviva is -18.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Innoviva has a P/B Ratio of 1.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Innoviva's valuation and earnings.
  • Percentage of Shares Shorted

    15.56% of the float of Innoviva has been sold short.
  • Short Interest Ratio / Days to Cover

    Innoviva has a short interest ratio ("days to cover") of 11.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Innoviva has recently increased by 3.99%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Innoviva does not currently pay a dividend.

  • Dividend Growth

    Innoviva does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    15.56% of the float of Innoviva has been sold short.
  • Short Interest Ratio / Days to Cover

    Innoviva has a short interest ratio ("days to cover") of 11.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Innoviva has recently increased by 3.99%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Innoviva has a news sentiment score of 1.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Innoviva this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for INVA on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Innoviva insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.25% of the stock of Innoviva is held by insiders.

  • Percentage Held by Institutions

    99.12% of the stock of Innoviva is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Innoviva's insider trading history.
Receive INVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innoviva and its competitors with MarketBeat's FREE daily newsletter.

INVA Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

INVA Stock Analysis - Frequently Asked Questions

Innoviva's stock was trading at $17.35 at the beginning of the year. Since then, INVA shares have increased by 9.9% and is now trading at $19.06.

Innoviva, Inc. (NASDAQ:INVA) posted its earnings results on Wednesday, May, 7th. The biotechnology company reported $0.25 earnings per share for the quarter. The biotechnology company had revenue of $88.63 million for the quarter. Innoviva had a positive trailing twelve-month return on equity of 15.77% and a negative net margin of 16.15%.

Innoviva's top institutional shareholders include Exchange Traded Concepts LLC (0.29%) and Parallel Advisors LLC.
View institutional ownership trends
.

Shares of INVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Innoviva investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
5/07/2025
Today
7/11/2025
Next Earnings (Estimated)
7/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Large Cap Pharma
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:INVA
Previous Symbol
NASDAQ:THRX
CIK
1080014
Employees
100
Year Founded
1996

Price Target and Rating

High Price Target
$55.00
Low Price Target
$55.00
Potential Upside/Downside
+188.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
57.76
P/E Growth
N/A
Net Income
$23.39 million
Net Margins
-16.15%
Pretax Margin
-12.53%
Return on Equity
15.77%
Return on Assets
8.41%

Debt

Debt-to-Equity Ratio
0.40
Current Ratio
2.48
Quick Ratio
2.30

Sales & Book Value

Annual Sales
$358.71 million
Price / Sales
3.34
Cash Flow
$3.40 per share
Price / Cash Flow
5.60
Book Value
$11.03 per share
Price / Book
1.73

Miscellaneous

Outstanding Shares
62,780,000
Free Float
61,363,000
Market Cap
$1.20 billion
Optionable
Optionable
Beta
0.37

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:INVA) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners